Friday, 16 October 2026
USUnited States
INIndiaNSE and BSE IPOs, GMP, stocksUSUnited StatesSEC IPO filings, Treasury yields, FedEUEuropeIPOs, ECB rates, euro exchange rates
Xflot
AboutDaily briefsContact Search
Business TodayUS IPO calendarNew SEC filingsTreasury & FedNasdaqNYSEAI
Brent rises to $101.50 as a Gulf of Mexico storm threatens 15% of US crude output and fighting flares in YemenApplied Digital's quarterly revenue quadruples to $341.9 million; data-centre leases reach 1.41 GW and about $36 billionMicrosoft opens orders for a $2,599 Surface Laptop Ultra on Nvidia's RTX Spark chip and moves Copilot onto the PCAnthropic launches Claude Haiku 5.5 at $0.10 per million input tokens, 90% below Haiku 4.5 for shorter requestsWebull falls 19% after a House panel says its ownership, staff and technology are tied to ChinaDow drops 341 points as the US 10-year yield reaches 5.36%, a 24-year high; S&P 500 and Nasdaq slip 0.2% from recordsFed minutes: most officials saw one more rate increase by year-end; they split on why they raised in SeptemberMicron's Taoyuan union wins a 99% strike mandate in a bonus dispute; shares slip over 2% before the bellChevron hands its Hess Midstream stake and DJ Basin pipelines to Hess Midstream; books a $3-4 billion lossFrasers Group discloses an 8.8% stake in Under Armour, about 16.6 million shares worth roughly $80 million
Fed funds (effective) 3.88%US 2-year 4.77%US 10-year 5.10%Official rates →

United States · IPO calendar

Veri MedTech Holdings, Inc. IPO

in registration

Exchange, OTC
TickerVRHID
First filing seen7 May 2026
IndustryServices-Computer Processing & Data Preparation
HeadquartersMclean, VA
Incorporated inDE

SEC filings

FormWhat it isFiled
S-1/AAmended registration statement22 Sep 2026
S-1/AAmended registration statement18 Sep 2026
S-1/AAmended registration statement14 Sep 2026
S-1/AAmended registration statement9 Jun 2026
S-1/AAmended registration statement2 Jun 2026
S-1/AAmended registration statement7 May 2026

Filings: SEC EDGAR ↗

This page reports public filings and reported deal terms. It is not a recommendation to buy, sell or apply.